Published in Rheumatol Int on March 27, 2014
Mean Platelet Volume (MPV) as an indicator of disease activity and severity in lupus. F1000Res (2017) 0.75
Mean Platelet Volume and Immature Platelet Fraction in Autoimmune Disorders. Front Med (Lausanne) (2017) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost (2009) 4.30
Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des (2011) 4.16
Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis (1996) 3.41
The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract (2009) 3.24
Platelet activation: assessment and quantification. Eur Heart J (2001) 2.02
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost (2009) 1.92
Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke (2004) 1.76
Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, Tromsø, Norway. J Thromb Haemost (2009) 1.72
The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program (2011) 1.34
Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost (2008) 1.29
The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev (2009) 1.17
Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost (2006) 0.93
Mean platelet volume predicts early death in acute pulmonary embolism. Heart (2009) 0.93
Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future. Eur J Clin Invest (2010) 0.91
Stroke prediction using mean platelet volume in patients with atrial fibrillation. Platelets (2011) 0.89
Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians. Thromb Res (2009) 0.88
The prognostic value of mean platelet volume in decompensated heart failure. Emerg Med J (2010) 0.88
Frequency of thrombophilia-related genetic variations in patients with idiopathic pulmonary embolism in an urban emergency department. Clin Chem (2006) 0.85
Platelets and the antiphospholipid syndrome. Lupus (2008) 0.84
Inhibition of heparin/antithrombin III cofactor activity by anticardiolipin antibodies: a mechanism for thrombosis. Thromb Res (1993) 0.82
Is there a link between mean platelet volume and thrombotic events in antiphospholipid syndrome? Platelets (2013) 0.80
Measurement of haematological indices of chronic rheumatic disease with two newer generation automated systems, the H1 and H6000 (Technicon). Ann Rheum Dis (1991) 0.80
Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none. Thromb Haemost (2010) 0.78
Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation. Semin Thromb Hemost (2008) 0.78
Isolated thrombocytopenia: should we routinely screen for antiphospholipid antibodies? Conn Med (2011) 0.78
Reference range of mean platelet volume. Thromb Res (2011) 0.77
Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives. Blood (2009) 1.87
Hodgkin lymphoma transformation of chronic lymphocytic leukemia: cases report and discussion. Med Oncol (2013) 1.42
Coagulation profile in patients with H1N1 influenza A infection undergoing treatment for haematological malignancies. Blood Coagul Fibrinolysis (2014) 1.39
Comparative proteomic profiling of sera from patients with refractory multiple myeloma reveals potential biomarkers predicting response to bortezomib-based therapy. Pol Arch Intern Med (2017) 1.39
Megakaryocytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t(9;22;22) and a constitutional translocation t(3;7). Cancer Genet Cytogenet (2010) 0.88
Comparative proteome analysis of acute myeloid leukemia with and without maturation. J Proteomics (2012) 0.87
Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma. Ann Hematol (2007) 0.87
Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia. J Cancer Res Clin Oncol (2007) 0.87
Incidence and risk factors for central venous catheter-related thrombosis in hematological patients. Med Oncol (2013) 0.86
Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F359I mutation of BCR-ABL oncogene. J Appl Genet (2008) 0.85
Frequency of BCR-ABL gene mutations in Polish patients with chronic myeloid leukemia treated with imatinib: a final report of the MAPTEST study. Pol Arch Med Wewn (2009) 0.81
Genetic investigation of biological materials from patients after stem cell transplantation based on autosomal as well as Y-chromosomal markers. Int J Legal Med (2012) 0.80
Cancer procoagulant in patients with adenocarcinomas. Blood Coagul Fibrinolysis (2005) 0.79
Strategy of pre-emptive management of Epstein-Barr virus post-transplant lymphoproliferative disorder after stem cell transplantation: results of European transplant centers survey. Contemp Oncol (Pozn) (2012) 0.79
Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study. Anticancer Res (2009) 0.79
Analysis of boutique arrays: a universal method for the selection of the optimal data normalization procedure. Int J Mol Med (2013) 0.78
Resistance to acetylsalicylic acid in patients after ischemic stroke. Pol Arch Med Wewn (2008) 0.78
[The role of bone marrow cells immunophenotypic study by flow cytometry in diagnosing myelodysplastic syndrome]. Postepy Hig Med Dosw (Online) (2008) 0.78
[Role of adhesion molecules in a determination of progression stages and clinical prognosis of patients with Echinococcus multilocularis]. Wiad Parazytol (2004) 0.78
Analysis of the coding sequence and expression of the coiled-coil α-helical rod protein 1 gene in normal and neoplastic epithelial cervical cells. Int J Mol Med (2012) 0.78
[Autologous stem cell transplantation in the treatment of primary systemic amyloidosis]. Pol Merkur Lekarski (2009) 0.78
Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers. Med Oncol (2015) 0.77
Comparative proteomics in acute myeloid leukemia. Contemp Oncol (Pozn) (2012) 0.77
Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients. Am J Hematol (2014) 0.77
Treatment strategy based on gemcitabine-containing salvage chemotherapy used with intent to proceed to second stem cell transplant for patients with Hodgkin lymphoma relapsing after a prior autologous transplant. Leuk Lymphoma (2012) 0.77
Exercise capacity, arrhythmic risk profile, and pulmonary function is not influenced by intracoronary injection of bone marrow stem cells in patients with acute myocardial infarction. Int J Cardiol (2011) 0.77
Triploidy in rainbow trout determined by computer-assisted analysis. J Exp Zool A Comp Exp Biol (2005) 0.76
Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation. Med Oncol (2013) 0.76
[Massive pulmonary embolism in a patient with ulcerative colitis and hyperhomocysteinaemia -- a case report]. Kardiol Pol (2006) 0.76
Second malignancies after autologous haematopoietic stem cell transplantation following modified BEAM conditioning regimen in patients with Hodgkin lymphoma - characteristics and risk factor analysis. Contemp Oncol (Pozn) (2013) 0.75
Bortezomib has little ex vivo activity in chronic myeloid leukemia: individual tumor response testing comparative study in acute and chronic myeloid leukemia. Contemp Oncol (Pozn) (2012) 0.75
[Thrombotic complications of central venous catheters in hematooncological patients]. Przegl Lek (2010) 0.75
Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS). Int J Hematol (2014) 0.75
Fludarabine, treosulfan and etoposide sensitivity and the outcome of hematopoietic stem cell transplantation in childhood acute myeloid leukemia. Anticancer Res (2007) 0.75
[Pulmonary embolism as a first manifestation of synchronous occurrence of two neoplasms]. Kardiol Pol (2009) 0.75
[Oral contraceptives use increases venous thromboembolic risk even for minor surgical procedure - a case report]. Kardiol Pol (2008) 0.75
[Evaluation of a risk of a cross-reactivity with Echinococcus multilocularis-specific Em2plus antigen in patients with liver cancer]. Wiad Parazytol (2004) 0.75
Exudative pericarditis in a pregnant woman as the first sign of non-Hodgkin's lymphoma. Kardiol Pol (2011) 0.75
The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma. Eur J Haematol (2014) 0.75
Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia. Anticancer Res (2008) 0.75
[Thrombotic complications following the treatment of multiple myeloma with new agents]. Pol Merkur Lekarski (2011) 0.75
[Suppressive effect of high-dose chemotherapy (HDC) on the clonal growth of grafted peripheral blood granulocyte progenitors is reduced 72 hours after completion of HDC]. Pol Arch Med Wewn (2005) 0.75